Dr. Thomas James Dobleman, MD

Dr. Dobleman practices at Outpatient Surgical Specialties Center in Omaha, Nebraska.

Dr. Dobleman's NPI, 1447343405, was assigned on October 2, 2006. Dr. Dobleman graduated from David Geffen School of Medicine at UCLA in 1983. Dr. Dobleman holds Nebraska license 18235.

Dr. Dobleman's primary practice is Outpatient Surgical Specialties Center, at 11704 W Center Road, Suite 110, Omaha, NE 68144. The practice phone is (402) 691-1575.

Dr. Dobleman's primary practice is Outpatient Surgical Specialties Center in Omaha, Nebraska.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dobleman practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Dobleman's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Dobleman is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Dobleman's licenses on file in 3 states: Nebraska, Iowa and Illinois.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Dobleman treats.

CMS data shows 4,364 Medicare services from Dr. Dobleman across 23 procedure codes in 2024, for 290 Medicare patients. Medicare paid $125,164 for them.

CMS counts 290 Medicare patients who saw Dr. Dobleman in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dobleman's median patient age at 64, with 56% women.

In 2024, Dr. Dobleman wrote 1,000 Medicare Part D claims for 278 patients. 94% of them were for generic drugs. CMS names the drug for 891 of them, across 18 drugs with 11 or more claims each, at $12,277 in total drug cost. In 2023, CMS named 836 claims across 19 drugs.

Dr. Dobleman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Dobleman, published from 2013 to 2020. 2013 was the busiest year, with 2. The most frequent topics are Biomarkers, Tumor and Early Detection of Cancer. Dr. Dobleman has published most often in Laryngoscope.

CMS Open Payments shows 140 general payments to Dr. Dobleman from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Aerin Medical Inc. paid the most, $1,422.

Dmand AI lists 3 awards for Dr. Dobleman, most recently Chief of Staff in 2002.

Dr. Dobleman graduated from David Geffen School of Medicine at UCLA in 1983. Dr. Dobleman is a member of AOA, AAFPRS, NHS, ACS, American Rhinologic Society and ASCO.

Dr. Dobleman is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.